<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">CHF</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="1037" role="article" about="/commodorecompendium/chf" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div class="WordSection1">
<div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Congestive Heart Failure - Madeleine Alder </span></span></span></b></span></span></span></span></p>
</div>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Background</span></span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">HFrEF</span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Ischemic</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> (40%): Obstructive CAD, previous/current myocardial infarction</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">NICM</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> (60%): HTN, idiopathic, myocarditis, genetic/familial, valvular, tachycardia/PVC-induced, infiltrative (amyloid, sarcoid, hemochromatosis), Takotsubo/stress cardiomyopathy, peripartum CM, substance abuse, chemotherapy/toxin-induced, "burned out" hypertrophic cardiomyopathy</span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">HFpEF</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: </span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">HTN</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">, CAD, obesity, DM, infiltrative, hypertrophic cardiomyopathy</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Causes</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> of Heart Failure Exacerbations (<b>FAILURES</b>)</span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Forgetting</span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino"> medications or <b>taking</b> drugs that can worsen HF (e.g. BB, CCB, NSAIDs, TZDs), chemo (anthracyclines, trastuzumab)</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Arrhythmia</span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino">: AF, VT, PVCs; Increased arrhythmia burden on device check?</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Ischemia or Infarction or Infection</span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino">; myocarditis; Acute vascular dysfunction (e.g. endocarditis), especially mitral or aortic regurgitation.</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Lifestyle choices</span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino">: Dietary indiscretions - high salt, EtOH, excessive fluid intake. Obesity.</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Upregulation</span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino"> (pregnancy and hyperthyroidism)</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Renal failure</span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino">: acute, progression of CKD, or insufficient dialysis (Increased preload)</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Embolus </span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino">(pulmonary) or COPD (leads to increase right-sided afterload)</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Stenosis</span></span></b><span style="font-size:12.0pt"><span style="font-family:Palatino"> (worsening AS, RAS) leading to hypertensive crisis </span></span><span style="font-size:12.0pt"><span style="font-family:Wingdings"></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> high left-sided afterload</span></span></span></span></span></span></li>
</ul>
</li>
</ul>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Presentation</span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Congestion</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: shortness of breath, dyspnea on exertion, Orthopnea, PND</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Nausea</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">/poor po intake</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Confusion</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Exam</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: Edema (legs, sacrum); Rales, S3, S4, murmur (AS, MR), Elevated JVD, + Hepatojugular reflex, Ascites</span></span></span></span></span></span></li>
</ul>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></span></span></p>
</div>
<div class="WordSection2">
<ul>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">CBC</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">, CMP, Magnesium</span></span></span></span></span></span> </li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Lactate, Troponin, BNP </span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Pro-BNP if on Entresto)</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">TSH</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Iron studies</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">EKG</span></span></span></span></span></span></li>
<li><span style="page:WordSection2"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">CXR, TTE</span></span></span></span></span></span></li>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Determine Hemodynamic Profile</span></span></span></span></span></span> </li>
</ul>
</div>
<div class="WordSection3">
<p> </p>
<table class="TableGrid1" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
<tbody>
<tr>
<td colspan="2" style="border-bottom:1px solid black; width:41%; padding:0in 7px 0in 7px; height:13px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">                     <span style="color:white">Volume Status</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:28%; padding:0in 7px 0in 7px; height:13px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">Euvolemia</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:29%; padding:0in 7px 0in 7px; height:13px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">Hypervolemia</span></span></span></b></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:15%; padding:0in 7px 0in 7px; height:43px; background-color:white; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="margin-top:1px; margin-right:8px; margin-left:8px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Normal</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; margin-right:8px; margin-left:8px; text-align:center"> </p>
<p align="center" style="margin-top:1px; margin-right:8px; margin-left:8px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Cardiac Index</span></span></span></b></span></span></span></span></p>
<p> </p>
</td>
<td style="border-bottom:1px solid black; width:26%; padding:0in 7px 0in 7px; height:43px; background-color:#e7e6e6; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Warm Extremities</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"> </p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Adequate Urine Output</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"> </p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Normal Pulse Pressure</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:28%; padding:0in 7px 0in 7px; height:43px; background-color:#e7e6e6; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Warm and Dry</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Forrester Class I</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:29%; padding:0in 7px 0in 7px; height:43px; background-color:#e7e6e6; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Warm and Wet</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Forrester Class II</span></span></span></b></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:15%; padding:0in 7px 0in 7px; height:43px; background-color:white; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="margin-top:1px; margin-right:8px; margin-left:8px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Low</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; margin-right:8px; margin-left:8px; text-align:center"> </p>
<p align="center" style="margin-top:1px; margin-right:8px; margin-left:8px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Cardiac Index</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:26%; padding:0in 7px 0in 7px; height:58px; background-color:white; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Cardiogenic Shock</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"> </p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Cool Extremities</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"> </p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Renal Failure</span></span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"> </p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Narrow Pulse Pressure</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:28%; padding:0in 7px 0in 7px; height:58px; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Cold and Dry</span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Forrester Class III</span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:29%; padding:0in 7px 0in 7px; height:58px; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Cold and Wet</span></span></b></span></span></span></span></p>
<p align="center" style="margin-top:1px; text-align:center"><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Forrester Class IV</span></span></b></span></span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p><br/>
<span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Management</span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Telemetry</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">, Daily STANDING weights, 2 L fluid restriction, 2g sodium diet, Strict I/Os</span></span></span></span></span></span> </li>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Cold</span></span></b> <b><span style="font-size:12.0pt"><span style="font-family:Palatino">and Wet</span></span></b><span style="font-size:12.0pt"><span style="font-family:Wingdings">à</span></span> <span style="font-size:12.0pt"><span style="font-family:Palatino">may require ionotropic support or transfer to the CCU</span></span></span></span></span></span></li>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Warm and Wet</span></span></b> <span style="font-size:12.0pt"><span style="font-family:Wingdings">à</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> Diuresis</span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Diuresis</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">: Place on 2.5 x home dose of IV diuretic, dose BID-TID (DOSE Trial)</span></span></span></span></span></span>
<ul style="list-style-type:disc">
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Goal is to be net negative (generally 1-2 L per day, but patient dependent)</span></span></span></span></span></span></li>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Check BMP and Mg BID and keep K&gt;4 and Mg&gt;2</span></span></span></span></span></span></li>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Monitor UOP and weights to determine if dosing adequate</span></span></span></span></span></span></li>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Low threshold for substantial increase (double) in loop vs transition to drip</span></span></span></span></span></span></li>
<li><span style="page:WordSection3"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><wrapblock><shape filled="f" id="Text_x0020_Box_x0020_2" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF&#10;dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ&#10;gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI&#10;+gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb&#10;mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu&#10;ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y&#10;ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx&#10;jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5&#10;8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj&#10;MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEAcrx8HtYFAACPFgAA&#10;HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWzsWNtu2zgQfV9g/0HQu6uLrzHqFI6z&#10;LgoEbRCn22eGomMhpKgl6VsX+y/7LftlO0NKtiy5WdvblwJNAJmX4dGZIWc4o7fvNoJ7K6Z0KrOR&#10;H70JfY9lVCZp9jzyPz9OWwPf04ZkCeEyYyN/y7T/7vrXX96S4bMi+SKlHiBkekhG/sKYfBgEmi6Y&#10;IPqNzFkGc3OpBDHQVc9BosgakAUP4jDsBYKkmX+9h7olhnhLlV4AxSV9YcmEZCuiAZLTYXWk4Mjp&#10;/0cmw2z1XuWz/F4hc/pxda+8NBn5YLmMCDCRHxQThRh0g9qq5z3AZq4Eysv53NuM/E7cb3e7vreF&#10;zejGg16vH3cdINsYj4JEG0zXCeFtFGWuBn0Qd29cfPovDLr47XUUIOoIQaNCUudIMVs1tY5LrR+R&#10;343cePFOf5T2zAYGgSiOWjOUGLqw4PcywI46GeZKm/dMCg8bI18xauwxI6s7bRyPUsTqJacp59aG&#10;PMMBLXma4JjtbPWEK29F+MiHw5vINarqe5xoAxOw8fav0K+yFAg5ODafAwP3ajKExdBEZLSYPe1/&#10;Trr9eNzvXrV6427U6kThoDUeh3HrdjoOx2FnOrnq3PwFKggSdYZr8LscvAhpgG2nnDwX5xunGydc&#10;pFRJLefmDZUigGOWUgaeRw+cMYqcMxZA6wbKEWdeS5XkSlKmdd2nS5goHPlLlQ2LkNDacWkBFzzy&#10;wGWIOH6xYvWa/ErwUk6+Jlfgup9yhXgVGuwxrMALwK9Fsx31uhkLi4JXDqo2hDhQ6HTyphTREWJj&#10;FFahhnl6SeCCVWapWEljnevTlML9cBwOd3i2IPkeDS+DU0xUoEG0x9Z+B9d5M8wftfG36HzIXvaq&#10;wWV1Bhkw76Fq75Vc5ju0qKfPUy7qFsoFeivYpgqUmGRxFrfYcYMrUsNauBAXRC8qiGeBRYO61aMe&#10;xcvqHGOVOxfAygoRyiCsn4NTcglg5R6nex5I3FDoxIh3eIyq57BB4EisqyUuh6fn1mU1O53yU6Pw&#10;Iad9LK0BilMYujB0K+lSsMyU+ZXZHR24qGqbdUTNYyCKcWIgO9SLNNeljkS0TzxFlaDWD4RMGG/v&#10;ThGkfy8NWkeDQAWlF8Cqkoc4KTAKol6WOd45OajylPLUbK2FShi6GVzAoxtEnYAuiDL7A003/cuQ&#10;2k2k3mVIcRPpRCc7sDJoFzWRTvS2OlLYRGpfpN1VEyg+GwhUC4P4iHbRBVBXwaDJ6WycxkFa582j&#10;fdQ1vhVEilrIpbuQKtr0u0w+ITct82+zmdnsHhP1ZIt56RP8QuaupLFVjc7pNIVE+g4S3nuioNCD&#10;4gNKRvMJHnMuIVmkPIXrcyHV1/oYyoExYMb3MHEd+fqPJcGshH/IICG5ijodgDO204E0GDqqOvNU&#10;ncmWYiIhD4+gKM2pbaK84WVzrqT4AnnGGN8KUySj8G4gaFTZmRjM2X0P6lLKxmPbdpHhLpuh0SNb&#10;K2CB8Lj5QlReVBHg5OajdEkQWqlWTDhZnMjkeGnkPC0qDWdNnODazMyWM1tpWJtjgQTB6c6SgMYD&#10;NqwoUsEGqHlPjas+orAPpUZRaPCKxA2bl7JGO9lSDNbvZ8dzW3cgZik32AHCqJ2Ho1FUZgpBFVDk&#10;BL8GsKz1eQaG/zrye1h/PpWmOqxv8LbIPLPN2ZxQyKPuiR2Rvpenhi6mRKQcKlcoHDF0agYb1e+7&#10;mpGRyroJ4emTSmEZySQmZGEcTsMuPPG/E7bxWQNtw8AO1ZoAKnRdAX1MBdPeR7b2HqQg2QF4HPYA&#10;tAvQ+JJ2Azwa1MHBVGAetJK5Bu9IN94gFM/e/Sdv5Ll+B/sffof+owRdRZowL3YygR2+get640V2&#10;FYxgiew81cKyLEGPezi2B1EEm4Dvft3838uMP+De7K1nY5/zOLTYj+x2P3fcxY/XvfGfv3960neM&#10;ck1Pwji1SxiWms3yB/jG5ZINl1GABH42DGqfYq0rFp+O8XtvtX/9LwAAAP//AwBQSwMEFAAGAAgA&#10;AAAhAJJ9h+AdBwAASSAAABoAAABjbGlwYm9hcmQvdGhlbWUvdGhlbWUxLnhtbOxZS28bNxC+F+h/&#10;WOy9sWS9YiNyYMly3MQvREqKHCmJ2mXMXS5Iyo5uRXLqpUCBtOihAXrroSgaoAEa9NIfY8BBm/6I&#10;DrkvUqLiB1wgKGwBxu7sN8PhzOzM7PDO3WcR9Y4xF4TFbb96q+J7OB6xMYmDtv9osP3Zbd8TEsVj&#10;RFmM2/4MC//uxqef3EHrI0qSIUN8PAhxhD0QFIt11PZDKZP1lRUxAjISt1iCY3g2YTxCEm55sDLm&#10;6AQWiOjKaqXSXIkQif0NkCiVoB6Ff7EUijCivK/EYC9GEax+MJmQEdbY8VFVIcRMdCn3jhFt+yBz&#10;zE4G+Jn0PYqEhAdtv6L//JWNOytoPWOicgmvwbet/zK+jGF8tKrX5MGwWLReb9Sbm4V8DaByEddr&#10;9Zq9ZiFPA9BoBDtNdbFltla79QxrgNJLh+yt1latauEN+bUFnTcb6mfhNSiVX1/Ab293wYoWXoNS&#10;fGMB3+isdbZs+RqU4psL+FZlc6vesuRrUEhJfLSArjSatW6+2wIyYXTHCV9r1Ldbq5nwEgXRUESX&#10;WmLCYrks1iL0lPFtACggRZLEnpwleIJGEJNdRMmQE2+XBCEEXoJiJoBcWa1sV2rwX/3q+kp7FK1j&#10;ZHArvUATsUBS+nhixEki2/59kOobkLO3b0+fvzl9/vvpixenz3/N1taiLL4dFAcm3/ufvvnn1Zfe&#10;37/9+P7lt+nS83hh4t/98tW7P/78kHjYcWmKs+9ev3vz+uz7r//6+aVD+iZHQxM+IBEW3j4+8R6y&#10;CDbo0B8P+eU4BiEiJsdmHAgUI7WKQ35PhhZ6f4YocuA62LbjYw6pxgW8N31qKdwP+VQSh8QHYWQB&#10;9xijHcadVnig1jLMPJjGgXtxPjVxDxE6dq3dRbHl5d40gRxLXCK7IbbUPKQolijAMZaeesaOMHbs&#10;7gkhll33yIgzwSbSe0K8DiJOkwzI0IqmkmmHROCXmUtB8Ldlm73HXodR16638LGNhHcDUYfyA0wt&#10;M95DU4kil8gBiqhp8F0kQ5eS/RkfmbiekODpAFPm9cZYCBfPAYf9Gk5/AGnG7fY9OotsJJfkyCVz&#10;FzFmIrfYUTdEUeLC9kkcmtjPxRGEKPIOmXTB95j9hqh78AOKl7r7McGWu8/PBo8gw5oqlQGinky5&#10;w5f3MLPitz+jE4RdqWaTR1aK3eTEGR2daWCF9i7GFJ2gMcbeo88dGnRYYtm8VPp+CFllB7sC6z6y&#10;Y1Xdx1hgTzc3i3lylwgrZPs4YEv02ZvNJZ4ZiiPEl0neB6+bNu9BqYtcAXBAR0cmcJ9Avwfx4jTK&#10;gQAZRnAvlXoYIquAqXvhjtcZt/x3kXcM3sunlhoXeC+BB1+aBxK7yfNB2wwQtRYoA2aAoMtwpVtg&#10;sdxfsqjiqtmmTr6J/dKWboDuyGp6IhKf2wHN9T6N/673gQ7j7IdXjpftevodt2ArWV2y01mWTHbm&#10;+ptluPmupsv4mHz8Tc0WmsaHGOrIYsa66Wluehr/f9/TLHufbzqZZf3GTSfjQ4dx08lkw5Xr6WTK&#10;5gX6GjXwSAc9euwTLZ36TAilfTmjeFfowY+A75nxNhAVn55u4mIKmIRwqcocLGDhAo40j8eZ/ILI&#10;sB+iBKZDVV8JCUQmOhBewgQMjTTZKVvh6TTaY+N02FmtqsFmWlkFkiW90ijoMKiSKbrZKgd4hXit&#10;baAHrbkCivcyShiL2UrUHEq0cqIykh7rgtEcSuidXYsWaw4tbivxuasWtADVCq/AB7cHn+ltv1EH&#10;FmCCeRw052Plp9TVuXe1M6/T08uMaUUANNh5BJSeXlO6Lt2e2l0aahfwtKWEEW62EtoyusETIXwG&#10;Z9GpqBdR47K+XitdaqmnTKHXg9Aq1Wjd/pAWV/U18M3nBhqbmYLG3knbb9YaEDIjlLT9CQyN4TJK&#10;IHaE+uZCNIDjlpHk6Qt/lcyScCG3kAhTg+ukk2aDiEjMPUqitq+2X7iBxjqHaN2qq5AQPlrl1iCt&#10;fGzKgdNtJ+PJBI+k6XaDoiyd3kKGT3OF86lmvzpYcbIpuLsfjk+8IZ3yhwhCrNGqKgOOiYCzg2pq&#10;zTGBw7AikZXxN1eYsrRrnkbpGErpiCYhyiqKmcxTuE7lhTr6rrCBcZftGQxqmCQrhMNAFVjTqFY1&#10;LapGqsPSqns+k7KckTTLmmllFVU13VnMWiEvA3O2vFqRN7TKTQw5zazwaeqeT7lrea6b6xOKKgEG&#10;L+znqLoXKAiGauVilmpK48U0rHJ2RrVrR77Bc1S7SJEwsn4zFztnt6JGOJcD4pUqP/DNRy2QJnlf&#10;qS3tOtjeQ4k3DKptHw6XYTj4DK7geNoH2qqirSoaXMGZM5SL9KC47WcXOQWep5QCU8sptRxTzyn1&#10;nNLIKY2c0swpTd/TJ6pwiq8OU30vPzCFGpYdsGa9hX36v/EvAAAA//8DAFBLAwQUAAYACAAAACEA&#10;nGZGQbsAAAAkAQAAKgAAAGNsaXBib2FyZC9kcmF3aW5ncy9fcmVscy9kcmF3aW5nMS54bWwucmVs&#10;c4SPzQrCMBCE74LvEPZu0noQkSa9iNCr1AcIyTYtNj8kUezbG+hFQfCyMLPsN7NN+7IzeWJMk3cc&#10;aloBQae8npzhcOsvuyOQlKXTcvYOOSyYoBXbTXPFWeZylMYpJFIoLnEYcw4nxpIa0cpEfUBXNoOP&#10;VuYio2FBqrs0yPZVdWDxkwHii0k6zSF2ugbSL6Ek/2f7YZgUnr16WHT5RwTLpRcWoIwGMwdKV2ed&#10;NS1dgYmGff0m3gAAAP//AwBQSwECLQAUAAYACAAAACEAu+VIlAUBAAAeAgAAEwAAAAAAAAAAAAAA&#10;AAAAAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQCtMD/xwQAAADIBAAALAAAA&#10;AAAAAAAAAAAAADYBAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQByvHwe1gUAAI8WAAAfAAAA&#10;AAAAAAAAAAAAACACAABjbGlwYm9hcmQvZHJhd2luZ3MvZHJhd2luZzEueG1sUEsBAi0AFAAGAAgA&#10;AAAhAJJ9h+AdBwAASSAAABoAAAAAAAAAAAAAAAAAMwgAAGNsaXBib2FyZC90aGVtZS90aGVtZTEu&#10;eG1sUEsBAi0AFAAGAAgAAAAhAJxmRkG7AAAAJAEAACoAAAAAAAAAAAAAAAAAiA8AAGNsaXBib2Fy&#10;ZC9kcmF3aW5ncy9fcmVscy9kcmF3aW5nMS54bWwucmVsc1BLBQYAAAAABQAFAGcBAACLEAAAAAA=&#10;" strokecolor="windowText" style="position:absolute; left:0; text-align:left; margin-left:5px; margin-top:18px; width:252pt; height:15.65pt; text-indent:0; z-index:-251656192; v-text-anchor:middle" type="#_x0000_t202"> <textbox/></shape></wrapblock><span style="font-size:12.0pt"><span style="font-family:Palatino">Can also augment with sequential nephron blockade (thiazides, acetazolamide)</span></span><wrapblock><shape filled="f" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF&#10;dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ&#10;gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI&#10;+gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb&#10;mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu&#10;ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y&#10;ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx&#10;jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5&#10;8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj&#10;MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEAcrx8HtYFAACPFgAA&#10;HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWzsWNtu2zgQfV9g/0HQu6uLrzHqFI6z&#10;LgoEbRCn22eGomMhpKgl6VsX+y/7LftlO0NKtiy5WdvblwJNAJmX4dGZIWc4o7fvNoJ7K6Z0KrOR&#10;H70JfY9lVCZp9jzyPz9OWwPf04ZkCeEyYyN/y7T/7vrXX96S4bMi+SKlHiBkekhG/sKYfBgEmi6Y&#10;IPqNzFkGc3OpBDHQVc9BosgakAUP4jDsBYKkmX+9h7olhnhLlV4AxSV9YcmEZCuiAZLTYXWk4Mjp&#10;/0cmw2z1XuWz/F4hc/pxda+8NBn5YLmMCDCRHxQThRh0g9qq5z3AZq4Eysv53NuM/E7cb3e7vreF&#10;zejGg16vH3cdINsYj4JEG0zXCeFtFGWuBn0Qd29cfPovDLr47XUUIOoIQaNCUudIMVs1tY5LrR+R&#10;343cePFOf5T2zAYGgSiOWjOUGLqw4PcywI46GeZKm/dMCg8bI18xauwxI6s7bRyPUsTqJacp59aG&#10;PMMBLXma4JjtbPWEK29F+MiHw5vINarqe5xoAxOw8fav0K+yFAg5ODafAwP3ajKExdBEZLSYPe1/&#10;Trr9eNzvXrV6427U6kThoDUeh3HrdjoOx2FnOrnq3PwFKggSdYZr8LscvAhpgG2nnDwX5xunGydc&#10;pFRJLefmDZUigGOWUgaeRw+cMYqcMxZA6wbKEWdeS5XkSlKmdd2nS5goHPlLlQ2LkNDacWkBFzzy&#10;wGWIOH6xYvWa/ErwUk6+Jlfgup9yhXgVGuwxrMALwK9Fsx31uhkLi4JXDqo2hDhQ6HTyphTREWJj&#10;FFahhnl6SeCCVWapWEljnevTlML9cBwOd3i2IPkeDS+DU0xUoEG0x9Z+B9d5M8wftfG36HzIXvaq&#10;wWV1Bhkw76Fq75Vc5ju0qKfPUy7qFsoFeivYpgqUmGRxFrfYcYMrUsNauBAXRC8qiGeBRYO61aMe&#10;xcvqHGOVOxfAygoRyiCsn4NTcglg5R6nex5I3FDoxIh3eIyq57BB4EisqyUuh6fn1mU1O53yU6Pw&#10;Iad9LK0BilMYujB0K+lSsMyU+ZXZHR24qGqbdUTNYyCKcWIgO9SLNNeljkS0TzxFlaDWD4RMGG/v&#10;ThGkfy8NWkeDQAWlF8Cqkoc4KTAKol6WOd45OajylPLUbK2FShi6GVzAoxtEnYAuiDL7A003/cuQ&#10;2k2k3mVIcRPpRCc7sDJoFzWRTvS2OlLYRGpfpN1VEyg+GwhUC4P4iHbRBVBXwaDJ6WycxkFa582j&#10;fdQ1vhVEilrIpbuQKtr0u0w+ITct82+zmdnsHhP1ZIt56RP8QuaupLFVjc7pNIVE+g4S3nuioNCD&#10;4gNKRvMJHnMuIVmkPIXrcyHV1/oYyoExYMb3MHEd+fqPJcGshH/IICG5ijodgDO204E0GDqqOvNU&#10;ncmWYiIhD4+gKM2pbaK84WVzrqT4AnnGGN8KUySj8G4gaFTZmRjM2X0P6lLKxmPbdpHhLpuh0SNb&#10;K2CB8Lj5QlReVBHg5OajdEkQWqlWTDhZnMjkeGnkPC0qDWdNnODazMyWM1tpWJtjgQTB6c6SgMYD&#10;NqwoUsEGqHlPjas+orAPpUZRaPCKxA2bl7JGO9lSDNbvZ8dzW3cgZik32AHCqJ2Ho1FUZgpBFVDk&#10;BL8GsKz1eQaG/zrye1h/PpWmOqxv8LbIPLPN2ZxQyKPuiR2Rvpenhi6mRKQcKlcoHDF0agYb1e+7&#10;mpGRyroJ4emTSmEZySQmZGEcTsMuPPG/E7bxWQNtw8AO1ZoAKnRdAX1MBdPeR7b2HqQg2QF4HPYA&#10;tAvQ+JJ2Azwa1MHBVGAetJK5Bu9IN94gFM/e/Sdv5Ll+B/sffof+owRdRZowL3YygR2+get640V2&#10;FYxgiew81cKyLEGPezi2B1EEm4Dvft3838uMP+De7K1nY5/zOLTYj+x2P3fcxY/XvfGfv3960neM&#10;ck1Pwji1SxiWms3yB/jG5ZINl1GABH42DGqfYq0rFp+O8XtvtX/9LwAAAP//AwBQSwMEFAAGAAgA&#10;AAAhAJJ9h+AdBwAASSAAABoAAABjbGlwYm9hcmQvdGhlbWUvdGhlbWUxLnhtbOxZS28bNxC+F+h/&#10;WOy9sWS9YiNyYMly3MQvREqKHCmJ2mXMXS5Iyo5uRXLqpUCBtOihAXrroSgaoAEa9NIfY8BBm/6I&#10;DrkvUqLiB1wgKGwBxu7sN8PhzOzM7PDO3WcR9Y4xF4TFbb96q+J7OB6xMYmDtv9osP3Zbd8TEsVj&#10;RFmM2/4MC//uxqef3EHrI0qSIUN8PAhxhD0QFIt11PZDKZP1lRUxAjISt1iCY3g2YTxCEm55sDLm&#10;6AQWiOjKaqXSXIkQif0NkCiVoB6Ff7EUijCivK/EYC9GEax+MJmQEdbY8VFVIcRMdCn3jhFt+yBz&#10;zE4G+Jn0PYqEhAdtv6L//JWNOytoPWOicgmvwbet/zK+jGF8tKrX5MGwWLReb9Sbm4V8DaByEddr&#10;9Zq9ZiFPA9BoBDtNdbFltla79QxrgNJLh+yt1latauEN+bUFnTcb6mfhNSiVX1/Ab293wYoWXoNS&#10;fGMB3+isdbZs+RqU4psL+FZlc6vesuRrUEhJfLSArjSatW6+2wIyYXTHCV9r1Ldbq5nwEgXRUESX&#10;WmLCYrks1iL0lPFtACggRZLEnpwleIJGEJNdRMmQE2+XBCEEXoJiJoBcWa1sV2rwX/3q+kp7FK1j&#10;ZHArvUATsUBS+nhixEki2/59kOobkLO3b0+fvzl9/vvpixenz3/N1taiLL4dFAcm3/ufvvnn1Zfe&#10;37/9+P7lt+nS83hh4t/98tW7P/78kHjYcWmKs+9ev3vz+uz7r//6+aVD+iZHQxM+IBEW3j4+8R6y&#10;CDbo0B8P+eU4BiEiJsdmHAgUI7WKQ35PhhZ6f4YocuA62LbjYw6pxgW8N31qKdwP+VQSh8QHYWQB&#10;9xijHcadVnig1jLMPJjGgXtxPjVxDxE6dq3dRbHl5d40gRxLXCK7IbbUPKQolijAMZaeesaOMHbs&#10;7gkhll33yIgzwSbSe0K8DiJOkwzI0IqmkmmHROCXmUtB8Ldlm73HXodR16638LGNhHcDUYfyA0wt&#10;M95DU4kil8gBiqhp8F0kQ5eS/RkfmbiekODpAFPm9cZYCBfPAYf9Gk5/AGnG7fY9OotsJJfkyCVz&#10;FzFmIrfYUTdEUeLC9kkcmtjPxRGEKPIOmXTB95j9hqh78AOKl7r7McGWu8/PBo8gw5oqlQGinky5&#10;w5f3MLPitz+jE4RdqWaTR1aK3eTEGR2daWCF9i7GFJ2gMcbeo88dGnRYYtm8VPp+CFllB7sC6z6y&#10;Y1Xdx1hgTzc3i3lylwgrZPs4YEv02ZvNJZ4ZiiPEl0neB6+bNu9BqYtcAXBAR0cmcJ9Avwfx4jTK&#10;gQAZRnAvlXoYIquAqXvhjtcZt/x3kXcM3sunlhoXeC+BB1+aBxK7yfNB2wwQtRYoA2aAoMtwpVtg&#10;sdxfsqjiqtmmTr6J/dKWboDuyGp6IhKf2wHN9T6N/673gQ7j7IdXjpftevodt2ArWV2y01mWTHbm&#10;+ptluPmupsv4mHz8Tc0WmsaHGOrIYsa66Wluehr/f9/TLHufbzqZZf3GTSfjQ4dx08lkw5Xr6WTK&#10;5gX6GjXwSAc9euwTLZ36TAilfTmjeFfowY+A75nxNhAVn55u4mIKmIRwqcocLGDhAo40j8eZ/ILI&#10;sB+iBKZDVV8JCUQmOhBewgQMjTTZKVvh6TTaY+N02FmtqsFmWlkFkiW90ijoMKiSKbrZKgd4hXit&#10;baAHrbkCivcyShiL2UrUHEq0cqIykh7rgtEcSuidXYsWaw4tbivxuasWtADVCq/AB7cHn+ltv1EH&#10;FmCCeRw052Plp9TVuXe1M6/T08uMaUUANNh5BJSeXlO6Lt2e2l0aahfwtKWEEW62EtoyusETIXwG&#10;Z9GpqBdR47K+XitdaqmnTKHXg9Aq1Wjd/pAWV/U18M3nBhqbmYLG3knbb9YaEDIjlLT9CQyN4TJK&#10;IHaE+uZCNIDjlpHk6Qt/lcyScCG3kAhTg+ukk2aDiEjMPUqitq+2X7iBxjqHaN2qq5AQPlrl1iCt&#10;fGzKgdNtJ+PJBI+k6XaDoiyd3kKGT3OF86lmvzpYcbIpuLsfjk+8IZ3yhwhCrNGqKgOOiYCzg2pq&#10;zTGBw7AikZXxN1eYsrRrnkbpGErpiCYhyiqKmcxTuE7lhTr6rrCBcZftGQxqmCQrhMNAFVjTqFY1&#10;LapGqsPSqns+k7KckTTLmmllFVU13VnMWiEvA3O2vFqRN7TKTQw5zazwaeqeT7lrea6b6xOKKgEG&#10;L+znqLoXKAiGauVilmpK48U0rHJ2RrVrR77Bc1S7SJEwsn4zFztnt6JGOJcD4pUqP/DNRy2QJnlf&#10;qS3tOtjeQ4k3DKptHw6XYTj4DK7geNoH2qqirSoaXMGZM5SL9KC47WcXOQWep5QCU8sptRxTzyn1&#10;nNLIKY2c0swpTd/TJ6pwiq8OU30vPzCFGpYdsGa9hX36v/EvAAAA//8DAFBLAwQUAAYACAAAACEA&#10;nGZGQbsAAAAkAQAAKgAAAGNsaXBib2FyZC9kcmF3aW5ncy9fcmVscy9kcmF3aW5nMS54bWwucmVs&#10;c4SPzQrCMBCE74LvEPZu0noQkSa9iNCr1AcIyTYtNj8kUezbG+hFQfCyMLPsN7NN+7IzeWJMk3cc&#10;aloBQae8npzhcOsvuyOQlKXTcvYOOSyYoBXbTXPFWeZylMYpJFIoLnEYcw4nxpIa0cpEfUBXNoOP&#10;VuYio2FBqrs0yPZVdWDxkwHii0k6zSF2ugbSL6Ek/2f7YZgUnr16WHT5RwTLpRcWoIwGMwdKV2ed&#10;NS1dgYmGff0m3gAAAP//AwBQSwECLQAUAAYACAAAACEAu+VIlAUBAAAeAgAAEwAAAAAAAAAAAAAA&#10;AAAAAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQCtMD/xwQAAADIBAAALAAAA&#10;AAAAAAAAAAAAADYBAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQByvHwe1gUAAI8WAAAfAAAA&#10;AAAAAAAAAAAAACACAABjbGlwYm9hcmQvZHJhd2luZ3MvZHJhd2luZzEueG1sUEsBAi0AFAAGAAgA&#10;AAAhAJJ9h+AdBwAASSAAABoAAAAAAAAAAAAAAAAAMwgAAGNsaXBib2FyZC90aGVtZS90aGVtZTEu&#10;eG1sUEsBAi0AFAAGAAgAAAAhAJxmRkG7AAAAJAEAACoAAAAAAAAAAAAAAAAAiA8AAGNsaXBib2Fy&#10;ZC9kcmF3aW5ncy9fcmVscy9kcmF3aW5nMS54bWwucmVsc1BLBQYAAAAABQAFAGcBAACLEAAAAAA=&#10;" strokecolor="windowText" style="position:absolute; left:0; text-align:left; margin-left:5px; margin-top:18px; width:252pt; height:15.65pt; text-indent:0; z-index:-251656192; v-text-anchor:middle" type="#_x0000_t202"><textbox/></shape></wrapblock></span></span></span></span></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<p> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino"> Goal-Directed Medical Therapy</span></span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">ACE-Inhibitors/ARBs</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Blocks harmful effects of renin-angiotensin-aldosterone system activation and attenuates adverse cardiac and vascular remodeling</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">If planning on using Entresto eventually, favor ARB over ACE-i in short term</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Sacubitril-valsartan (Entresto):  Additional benefit of Neprilysin inhibition</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">36-hour washout after stopping ACE-i before starting Entresto to avoid angioedema</span></span></span></span></span></li>
</ul>
</li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Aldosterone receptor antagonists</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Diuretic and blood pressure lowering effects and blocks deleterious effects of aldosterone on the heart (including hypertrophy and fibrosis)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">May also reduce hospitalizations in HFpEF</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Worry about hyperkalemia: avoid if CrCl&lt;30 or K&gt;5</span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Beta-blockers</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Reduces catecholamine stimulation including elevated heart rate, increased myocardial energy demands, adverse remodeling due to cardiac myocyte hypertrophy and death</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Mortality benefit shown with carvedilol, metoprolol succinate or bisoprolol</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Avoid if pt is decompensated (cold); “start low and go slow”</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Can continue during exacerbation if patient compensated, (ie not in shock)</span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Hydralazine/Isosorbide Dinitrate</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Reduces cardiac afterload and preload and may also enhance nitric oxide bioavailability </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Reduction in mortality for African American patients</span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">SGLT-2 inhibitors</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Osmotic diuresis and natriuresis, improve myocardial metabolism, inhibit sodium-hydrogen exchange in myocardium, reduce cardiac fibrosis</span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Cardiac resynchronization therapy (CRT)</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Criteria: HFrEF with LVEF ≤35%, QRS ≥150 ms with left bundle branch block (LBBB); NYHA class II to ambulatory class IV HF and wide QRS</span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Mitra Clip</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Criteria: mitral regurgitation of 3-4+, on maximally tolerated GDMT, an ejection fraction &gt;20%, and a left ventricle end-systolic dimension of less than 7 cm</span></span></span></span></span></li>
</ul>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Iron</span></span></span></b><b><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino"> repletion</span></span></span></b></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Criteria: ferritin &lt;100 µg/L or ferritin 100-299 µg/L AND transferrin saturation &lt;20%.</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Replete intravenous (IV) iron. IV iron sucrose (500 mg x2 doses 48 hours apart) or ferric carboxymaltose (maximum dose of 1000 mg per week) or iron dextran (1 g x1)</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:107%"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="line-height:107%"><span style="font-family:Palatino">Additional Information: </span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">ICD placement (See Below, eg <a href="https://medsites.vumc.org/commodorecompendium/cardiac-devices">Cardiac Devices</a>)</span></span></b></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Starting patients on low dose of multiple agents preferred to max dose of single agent</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">D/C summary should have discharge weight, diuretic regimen, and renal function</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Daily weights at home with rescue diuretic plan (pm dose for 3 lbs in 1 day, 5 lbs in 3 days)</span></span></span></span></span></li>
</ul>
</div>
</div>
</article>
</div>
</div>